Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reham, Sameh"'
Publikováno v:
Middle East Journal of Cancer, Vol 15, Iss 4, Pp 289-296 (2024)
Background: Triple-negative breast cancer (TNBC) is characterized by a poor prognosis. Consequently, the current research aims to identify new therapeutic targets for TNBC patients. Trichorhinophalangeal syndrome type 1 (TRPS1), a novel GATA transcri
Externí odkaz:
https://doaj.org/article/da71bd9508b0499cbf962f1a9082f2c5
Autor:
Samia, Hussein, Ahmed El Shabrawy, Lasheen, Amr A, Abdelrahman, Amira S, Al-Karamany, Reham, Sameh, Ahmed, Algazeery
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:1761-1768
Ovarian cancer is the fifth leading cause of cancer-related deaths among women worldwide. Unfortunately, early detection tests are relatively lacking. Diagnosis in the late stages of the disease carries a poor prognosis.To evaluate the relationship b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9025a42f07aea69273eaa7f0b04dba
https://doi.org/10.31557/apjcp.2022.23.5.1761
https://doi.org/10.31557/apjcp.2022.23.5.1761
Autor:
Lobna A. Abdelaziz, Hayam E. Rashed, Reham Sameh, Eman A. Elsebai, Shireen S. Muhammad, Nashwa Nawar, Mohamed I. Abdelhamid
Publikováno v:
Revista de Senología y Patología Mamaria. 34:200-207
Introduction Immune system plays an important role in behavior of cancer. Breast cancer and its stroma display high levels of immune-cell infiltrates (tumor-infiltrating lymphocytes TILs). Programmed cell death-ligand 1 (PD-L1) is one key inhibitor m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::42a8aea666df22ea7d1c4ea3366165d1
https://doi.org/10.1016/j.senol.2020.12.006
https://doi.org/10.1016/j.senol.2020.12.006
Autor:
Reham Sameh, Mohamed Fawzy Ramadan, Naglaa A. Mostafa, Khaled Abdelwahab, Samar M. Abdel-Raouf
Publikováno v:
Journal of histotechnology. 45(1)
Enhancer of zeste homolog 2 (EZH2) and AT-rich interactive domain 1A (ARID1A) expression in urothelial carcinoma (UC) has not been well studied. ARID1A is a novel tumor suppressor gene coding for a chromatin remodeling protein that is mutated in urin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6168c71254f0a856a5fd5126d5ca58c5
https://pubmed.ncbi.nlm.nih.gov/34493171
https://pubmed.ncbi.nlm.nih.gov/34493171
Autor:
Ahmad Embaby, Reham Sameh, Samia Hussein, Sherin Elshorbagy, Norhan A. Sabbah, Haitham Mohamed, Tarek Khamis, Huda F. Ebian
Publikováno v:
Cancer biomarkers : section A of Disease markers. 32(3)
BACKGROUND: Both Fms-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) and Additional Sex Comb-like 1 (ASXL1) mutations are frequent and early genetic alteration events in acute myeloid leukemia (AML) patients. These genetic alterations m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02799e89bdf1d5f91e3ef4dda6bdb65a
https://pubmed.ncbi.nlm.nih.gov/34487021
https://pubmed.ncbi.nlm.nih.gov/34487021